BSE · 539559
Deep Health AI India Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹0 Cr with net profit ₹-5 Cr — a -1808% net margin, versus 640% the period before.
Shareholding
As of 2026-06-30
- Promoter0.03%
- Public99.63%
- FII0.35%
91,618 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 6.24× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 1. Trading may carry price bands, periodic call auction or higher margins.
- 52-week range spans 6.24× (₹1.65 to ₹10.29) — an unusually wide band.
Peer comparison
Pharmaceuticals - Indian - Bulk Drugs & Formln · ranked #85 of 102 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | ₹4,80,707 Cr | 38.68 | 5.75 | 13.74% | 19.72% |
| Cipla Ltd. | ₹1,19,367 Cr | 215.08 | 3.47 | 11.27% | 14% |
| Zydus Lifesciences Ltd. | ₹1,12,309 Cr | 20.67 | 4.14 | 18.59% | 18.86% |
| Lupin Limited | ₹1,11,711 Cr | 19.64 | 4.98 | 23.76% | 19.4% |
| Mankind Pharma Limited | ₹1,06,776 Cr | 53 | 6.55 | 11.74% | 13.4% |
| Laurus Labs Limited | ₹96,062 Cr | 87.84 | 18.12 | 16.77% | 15.04% |
| Dr Reddys Laboratories Ltd. | ₹95,252 Cr | 430.64 | 2.51 | 0.11% | 0.12% |
| Aurobindo Pharma Ltd. | ₹92,754 Cr | 100.69 | 2.45 | 9.25% | 10.5% |
| Alkem Laboratories Ltd. | ₹69,354 Cr | 293.4 | 5.02 | 16.66% | 15.65% |
| Biocon Ltd. | ₹68,864 Cr | 537.78 | 2.02 | 1.14% | 2.3% |
| Deep Health AI India Limited(this company) | ₹30 Cr | 4.56 | 0.58 | 12.54% | 26.35% |
AI analysis
AI-generated · google/gemini-2.5-flashDeep Health AI India Limited has a market capitalization of Rs 30 Cr. The company's profit margin stands at 26.35% on a total revenue of Rs 3.65 Cr. The company's debt-to-equity ratio is 0.05.
Positives
- +The company's debt-to-equity ratio is low at 0.05.
- +The Return on Capital Employed (ROCE) is 14.29%.
- +The Return on Equity (ROE) is 12.54%.
- +The profit margin is 26.35%.
Negatives
- −Promoter holding is very low at 0.028% as of June 2026.
- −The company reported a negative net profit of Rs -4.51 Cr in March 2026.
- −The company is under ESM 1 surveillance as indicated by the 'ESM' risk flag.
- −The dividend yield of 486% appears unusually high and may warrant further scrutiny as a potential data anomaly.
- −No annual EPS figures were provided.
Financial Performance
Deep Health AI India Limited reported a revenue of Rs 3.65 Cr and a net profit of Rs 0.45 Cr, resulting in an EPS of 0.45. For the quarter ending March 2026, the company reported a revenue of Rs 0.25 Cr and a net loss of Rs -4.51 Cr. Over the year ending September 2025, revenue was Rs 3.35 Cr and net profit Rs 2.53 Cr. The company's highest quarterly revenue was Rs 3.35 Cr in September 2025.
Profitability & Returns
The company has a Return on Equity (ROE) of 12.54% and a Return on Capital Employed (ROCE) of 14.29%. The profit margin is 26.35%. However, the company reported a negative net profit of Rs -4.51 Cr in March 2026, indicating a recent decline in profitability.
Balance Sheet
Deep Health AI India Limited maintains a low debt position, with a debt-to-equity ratio of 0.05. The book value per share is Rs 3.56. The company's overall financial leverage appears to be limited based on this metric.
Ownership & Pledges
As of June 2026, the promoter holding in Deep Health AI India Limited is 0.028%, while public shareholding stands at 99.6251%. There are no promoter shares pledged. The company has a significant number of shareholders, at 91618 as of June 2026.
Regulatory & Surveillance
Deep Health AI India Limited is under ESM (Enhanced Surveillance Measure) Stage 1 surveillance, which often indicates heightened monitoring by regulatory bodies due to specific criteria being met. This measure suggests increased regulatory scrutiny.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Deep Health AI India Limitedshare price & fundamentals